Close
  Indian J Med Microbiol
 

Figure 1: Hybrid magnetic resonance-positron emission tomography imaging at the initial presentation 8 months after completion of the chemoradiotherapy. (a) Contrast-enhanced magnetic resonance imaging showing evidence of patchy areas of enhancement (black arrow) adjacent to the postoperative cavity (white arrow). (b) F-18 flourodeoxyglucose positron emission tomography image showing intense gyral uptake in the left parietal lobe (white arrow). Note that the uptake on F-18 flourodeoxyglucose is not corresponding to the areas of contrast enhancement

Figure 1: Hybrid magnetic resonance-positron emission tomography imaging at the initial presentation 8 months after completion of the chemoradiotherapy. (a) Contrast-enhanced magnetic resonance imaging showing evidence of patchy areas of enhancement (black arrow) adjacent to the postoperative cavity (white arrow). (b) F-18 flourodeoxyglucose positron emission tomography image showing intense gyral uptake in the left parietal lobe (white arrow). Note that the uptake on F-18 flourodeoxyglucose is not corresponding to the areas of contrast enhancement